Moreover, the results of the present study suggest that CIN-dependent activation of cGAS–STING signaling may contribute to cancer cell proliferation under EGFR-TKI treatment in a subset of EGFR-mutated NSCLC tumors. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.